Wenstrup Richard 4
4 · Oxford Immunotec Global PLC · Filed Mar 19, 2018
Insider Transaction Report
Form 4
Wenstrup Richard
Chief Medical Officer
Transactions
- Award
Ordinary Shares
2018-03-15+4,370→ 22,992 total - Award
Share Option (Right to Buy)
2018-03-15+19,112→ 19,112 totalExercise: $13.24Exp: 2028-03-15→ Ordinary Shares (19,112 underlying)
Footnotes (2)
- [F1]Options granted under Issuer's 2013 Share Incentive Plan.
- [F2]Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2019 through January 1, 2022.